Patient preferences in retinal drug delivery
Abstract Retinal vascular diseases (RVDs) are often treated with intravitreally (IVT) injected drugs, with relatively low patient compliance and potential risks. Ongoing research explores alternative RVD treatments, including eye drops and oral tablets. This study surveyed RVD patients treated with...
Main Authors: | Brandon Jacobs, Nicholas Palmer, Trupti Shetty, Helen Dimaras, Amir Hajrasouliha, Denis Jusufbegovic, Timothy W. Corson |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-98568-7 |
Similar Items
-
Mitochondrial Heme Synthesis Enzymes as Therapeutic Targets in Vascular Diseases
by: Trupti Shetty, et al.
Published: (2020-07-01) -
Retinal detachment repair through multifocal intraocular lens- overcoming visualization challenge of the peripheral retina
by: Amir Hadayer, et al.
Published: (2017-06-01) -
Measurement of mitochondrial respiration in the murine retina using a Seahorse extracellular flux analyzer
by: Trupti Shetty, et al.
Published: (2021-06-01) -
Nanotechnology in retinal drug delivery
by: Sibo Jiang, et al.
Published: (2018-06-01) -
Patient knowledge, experiences and preferences regarding retinoblastoma and research: A qualitative study
by: Catherine Moses, et al.
Published: (2020-06-01)